GMP Warning Letter: Teva Preempts FDA In Disclosing Problems At Jerusalem Plant

Generic giant Teva took the unusual step of disclosing the entire contents of a Jan. 31 FDA warning letter about good manufacturing process failings, as part of a Securities and Exchange Commission filing it posted online two days later.